Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$42.3B
sum of reported positions
Reported positions
227
Changes vs prior quarter
244
33 new · 48 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 284 measured positions in 8 quarters, the typical new or larger position finished −1.8 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $28.2B | $42.3B |
| Positions | 242 | 227 |
| Biggest line | — | Apple 7% |
| 5.56M |
| $1.99B |
| 4.7% |
| 2.84M | $1.65B | 3.9% |
| 1.22M | $1.41B | 3.3% |
| 493K | $1.12B | 2.7% |
| 2.36M | $1.02B | 2.4% |
| 984K | $950M | 2.2% |
| 6.71M | $937M | 2.2% |
| 2.93M | $883M | 2.1% |
| 2.13M | $805M | 1.9% |
| 3.06M | $781M | 1.8% |
| 1.92M | $685M | 1.6% |
| 1.57M | $617M | 1.5% |
| 1.73M | $611M | 1.4% |
| 1.67M | $570M | 1.3% |
| 939K | $529M | 1.3% |
| 793K | $507M | 1.2% |
| 1.56M | $451M | 1.1% |
| 2.53M | $430M | 1.0% |
| 1.15M | $418M | 1.0% |
| 538K | $411M | 1.0% |
| 2.49M | $404M | 1.0% |
| 1.97M | $368M | 0.9% |
Ryan Specialty (RYAN)
2.45M → 2.94M shares (+20%)
Brown & Brown (BRO)
1.44M → 1.73M shares (+20%)
Delta Air Lines (DAL)
762K → 1.14M shares (+50%)
Comfort Systems USA (FIX)
47K → 53K shares (+15%)
Reinsurance Group of America (RGA)
547K → 495K shares (−10%)
Scholar Rock Holding (SRRK)
1.98M → 1.88M shares (−5%)
Nu Holdings (NU)
8.27M → 7.7M shares (−7%)
Edwards Lifesciences (EW)
1.1M shares
Dianthus Therapeutics, Inc. (DNTH)
1.08M → 1.02M shares (−5%)
Mirum Pharmaceuticals (MIRM)
283K → 846K shares (+198%)
Insmed (INSM)
368K → 891K shares (+142%)
Progressive Corporation (PGR)
453K → 428K shares (−6%)
Praxis Precision Medicines (PRAX)
279K shares
Qnity Electronics (Q)
549K shares
Spyre Therapeutics (SYRE)
793K → 988K shares (+25%)
Knight-Swift (KNX)
1.12M shares
CRINETICS PHARMACEUTICALS IN
2.27M shares
Walmart (WMT)
604K → 748K shares (+24%)
Sea (SE)
792K → 874K shares (+10%)
US Foods (USFD)
652K → 806K shares (+24%)
Pharvaris (PHVS)
781K → 2.33M shares (+198%)
Analog Devices (ADI)
131K → 190K shares (+45%)
Cisco (CSCO)
276K → 618K shares (+124%)
Solventum (SOLV)
936K shares
Vaxcyte (PCVX)
1.43M → 1.19M shares (−17%)
